Please select the option that best describes you:

What non-taxane chemotherapy can you partner with trastuzumab/pertuzumab for HER2+ breast CA if neuropathy either at baseline or with treatment becomes prohibitive?  

What would you use either in adjuvant setting or in metastatic setting?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Hawaii Oncology Inc-Kuakini
Is there data for HP without cytotoxic chemo in th...
Medical Oncologist at H Lee Moffitt Cancer Center, University of South Florida
There is data from the PERTAIN trial using an AI p...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Northwestern Medicine Cancer Center at KishHealth
Thank you. That was very helpful. 
Medical Oncologist at Oncology & Hematology Specialists
👍👍
Medical Oncologist at H Lee Moffitt Cancer Center, University of South Florida
Thank you Muhammed. Although TDM1 is a nontaxane t...
Sign in or Register to read more